Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Ruchika Sharma5 Sept 2024 2:30 PM ISTBoehringer Ingelheim acquires Saiba Animal Health, strengthens animal health RnD pipelineIngelheim: Boehringer Ingelheim has said it has acquired...
Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod Ruchika Sharma18 May 2024 2:30 PM ISTMumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a...
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
Boehringer Ingelheim, Sosei Heptares collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia Ruchika Sharma11 March 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and Sosei Group Corporation have announced they have entered a global collaboration and exclusive...
Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals Ruchika Sharma7 March 2024 12:38 PM ISTGerman drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and...
Boehringer expands production site in Greece for new medicine Ruchika Sharma14 Jan 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim, a research-driven biopharmaceutical company, has announced a further expansion and upgrade of its plant in...
Boehringer Ingelheim, 3T Biosciences enter into second partnership for cancer immunotherapies Ruchika Sharma7 Jan 2024 10:00 AM ISTIngelheim: Boehringer Ingelheim and 3T Biosciences have announced they have entered into a new strategic collaboration and licensing agreement...
Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases Ruchika Sharma3 Jan 2024 1:53 PM ISTIngelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...
Boehringer Ingelheim receives approval for Senvelgo in Europe for diabetic cats Ruchika Sharma24 Nov 2023 3:30 PM ISTFeline diabetes mellitus is a metabolic disorder which occurs when a cat has insufficient levels of, or an abnormal response to insulin.
Boehringer Ingelheim expands immuno oncology portfolio with acquisition of bacterial cancer therapy specialist T3 Pharma Ruchika Sharma24 Nov 2023 1:30 PM ISTGermany: Boehringer Ingelheim has announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Aldosterone synthase inhibitor shows promise in CKD trial: Boehringer Ingelheim Ruchika Sharma5 Nov 2023 2:30 PM ISTGermany: Boehringer Ingelheim has announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor...
Boehringer Ingelheim, Zealand Pharma announce initiation of 3 phase III trials investigating Survodutide for obesity Ruchika Sharma8 Oct 2023 3:30 PM ISTIngelheim: Boehringer Ingelheim and Zealand Pharma A/S have announced the initiation of three Phase III trials investigating survodutide (also known...
